Archive Category: Green Zone Fortunes Updates

For this week’s video, I share a bit of a rant about one of my biggest pet peeves. It involves being a trader versus being an investor. By now, markets have recovered from their September pullback and are making new all-time highs. I’m confident in our open portfolio positions, and co-editor Charles Sizemore, research analyst Matt Clark and I are working on the November issue of Green Zone Fortunes right now.

In this week’s video, I recap the worry many investors felt in September. Stocks started drifting lower from the beginning of the month and pulled back about 5%. A 5% pullback is enough to make some people worry when they’re rare — and they are right now. But now, stocks are back to minting new all-time highs.

My team and I are hard at work this week to unveil the details about a trading window I just identified. I’m taking a break from that now to write up our portfolio update … but take it from me: You don’t want to miss this event! Mark your calendar for November 4 … and click here for the details! If you missed the October issue of the Green Zone Fortunes newsletter, click here to find out all about our latest high-conviction “Imperium” company. Now for our portfolio update…

Anyone who’s been diagnosed with a medical ailment — or whose loved one has — likely knows what I’m talking about when I say: The sooner you know, the better! To me, that’s what genetic testing — and, more broadly, the genomic revolution — is all about. It’s not about “engineering” the perfect child. It’s not about adding an arbitrary 20 years to the end of someone’s life.

In this week’s update, I discuss a portfolio stock whose business model is top-notch: Interactive Brokers Group Inc. (Nasdaq: IBKR). This is a popular brokerage with many professional traders … and for good reason. Last month, the company introduced crypto trading, which gives it another distinct advantage over most of its peers.